Directorate Change

UDG Healthcare plc

("UDG" or "the Company")

28 January 2021

Directorate Changes

Following a review of the composition of the Board Committees, UDG is pleased to announce the following Committee changes, all of which are effective from 1 February 2021:

Nominations, Governance & Sustainability Committee

Linda Wilding will step down from the Nominations, Governance & Sustainability Committee and Peter Chambré and Anne Whitaker will be appointed to this Committee.

Risk, Investment & Financing Committee

Shane Cooke will step down as Chair of the Risk, Investment & Financing Committee and will be replaced as Chair by Linda Wilding. Lisa Ricciardi will also step down from this Committee, with Liz Shanahan and Anne Whitaker being appointed to the Committee.

Remuneration Committee

Linda Wilding will step down as Chair of the Remuneration Committee and Peter Chambré will assume the role of Chair. Lisa Ricciardi will also step down as a member of the Remuneration Committee and Erik Van Snippenberg and Anne Whitaker will be appointed to this Committee.

Details of the composition of each Committee are available on our website at https://www.udghealthcare.com/investors/corporate-governance/board-committees/.

This announcement is made in accordance with Listing Rule 9.6.11(3).

For further information, please contact:

UDG Healthcare plc

Damien Moynagh

General Counsel & Company Secretary

+353 (1) 468 9000